Adrenal crisis
Recognising acute adrenal insufficiency, giving hydrocortisone before the tests come back, finding the trigger, and preventing the next crisis with sick-day rules.
Tier 1ConditionFree sample
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Acute adrenal insufficiency is shock with no other obvious cause in someone who can't make cortisol. It kills through hypotension and hypoglycaemia.
- Give hydrocortisone 100 mg IV or IM first. Take cortisol and ACTH if it doesn't delay treatment, but never wait for them.
- Most crises happen in people already known to have adrenal insufficiency or taking long-term glucocorticoids, who are hit by an illness and don't increase their dose.
- Every admission is a chance to prevent the next: sick-day rules, an emergency injection kit and a steroid card.
Causes
| Level | Causes |
|---|---|
| Primary (adrenal) | Autoimmune Addison disease (commonest in Australia), adrenal haemorrhage (anticoagulation, antiphospholipid syndrome, meningococcal sepsis: Waterhouse-Friderichsen), TB, metastases, congenital adrenal hyperplasia, adrenalectomy, drugs (ketoconazole, mitotane, etomidate) |
| Secondary (pituitary) | Pituitary tumour or surgery, apoplexy, radiotherapy, Sheehan syndrome, hypophysitis from immune checkpoint inhibitors |
| Tertiary (glucocorticoid-induced) | Long-term oral, inhaled, topical or injected glucocorticoids, stopped suddenly or not increased during illness. By far the commonest overall |
- Precipitants: gastroenteritis (vomiting means tablets aren't absorbed), infection, surgery, trauma, missed doses, and starting thyroxine before glucocorticoid replacement.
- Drug interactions: enzyme inducers (rifampicin, phenytoin, carbamazepine) speed cortisol clearance. Ritonavir or cobicistat with inhaled or injected fluticasone or triamcinolone causes iatrogenic Cushing syndrome, then adrenal insufficiency when either drug stops.
- Glucocorticoid-induced risk: the ESE/Endocrine Society 2024 guideline treats anyone on supraphysiological doses (prednisolone above about 4 to 5 mg daily, or hydrocortisone above 15 to 25 mg) for more than 3 to 4 weeks as at risk, whatever the route. The cut-off isn't a safe line: people on long-term doses at or near prednisolone 5 mg can still have a suppressed HPA axis and need sick-day rules.
Pathophysiology worth knowing
- Cortisol maintains vascular tone (it permits catecholamine action), gluconeogenesis and free water excretion. Without it you get vasodilatory shock that responds poorly to fluids and pressors, hypoglycaemia and hyponatraemia.
- Aldosterone is controlled by renin, not ACTH. Only primary disease loses it, giving hyperkalaemia, salt craving and more profound volume depletion.
- Hyperpigmentation (buccal mucosa, palmar creases, scars) comes from high ACTH and its precursor POMC, so it is a sign of primary disease.
Recognition
- Symptoms: profound fatigue, nausea, vomiting, abdominal pain (can mimic an acute abdomen), confusion, collapse.
- Signs: hypotension or postural drop, tachycardia, fever, reduced consciousness.
- Bloods:
- Hyponatraemia in about 80% (primary and secondary: cortisol deficiency raises ADH)
- Hyperkalaemia in primary only
- Hypoglycaemia, more common in children and in hypopituitarism
- Raised urea, mild hypercalcaemia, eosinophilia, normocytic anaemia
- Suspect it in hypotension that doesn't respond to fluids and vasopressors, recurrent hypoglycaemia in someone with type 1 diabetes (falling insulin needs are an early sign of Addison disease), or anyone wearing a medical alert bracelet.
- Pitfall: a normal potassium doesn't exclude adrenal crisis. Secondary and glucocorticoid-induced disease keep aldosterone.
Investigations
- Before hydrocortisone, if no delay: serum cortisol and plasma ACTH. Add renin and aldosterone when primary disease is possible.
- Prednisolone and hydrocortisone cross-react with cortisol immunoassays, so a random cortisol in someone taking them can't be interpreted. Dexamethasone doesn't cross-react.
- Interpreting a random cortisol in a sick patient: below about 100 nmol/L strongly supports adrenal insufficiency; a value well above 500 nmol/L makes it unlikely. Values between need a short synacthen test once the patient is stable. Assay cut-offs vary, so use the local laboratory's.
- ACTH: high in primary, low or inappropriately normal in secondary.
- Once stable: short synacthen test (250 µg tetracosactide, cortisol at 0 and 30 to 60 minutes). Hold hydrocortisone for 24 hours before testing, or switch to dexamethasone, which doesn't cross-react with the cortisol assay.
- Primary disease: 21-hydroxylase antibodies, then CT adrenals if antibody negative. Secondary: pituitary MRI and the other pituitary axes.
- Pitfall: a synacthen test done within about 4 to 6 weeks of a pituitary insult (surgery, apoplexy) can be falsely normal, because the adrenals haven't yet atrophied.
Management
Immediate
- Hydrocortisone 100 mg IV or IM as soon as the diagnosis is suspected. This is the step most often delayed in Australian emergency departments.
- Fluids: 0.9% sodium chloride, 1 L over the first hour, then guided by haemodynamics. Usually 3 to 4 L in the first 24 hours, with care in older people and heart failure.
- Glucose: check it and treat hypoglycaemia with IV dextrose.
- Hydrocortisone 200 mg per 24 hours after the bolus, as a continuous infusion or 50 mg every 6 hours IV or IM (NICE NG243, Endocrine Society 2016).
- Find and treat the trigger: cultures, chest X-ray, urine, lipase, ECG.
- Mineralocorticoid: not needed while hydrocortisone exceeds about 50 mg/day. Restart fludrocortisone (usually 50 to 200 µg daily) in primary disease once the dose is weaned.
- Hyponatraemia: correct no faster than 8 to 10 mmol/L in 24 hours. Hydrocortisone switches off ADH and can cause a brisk water diuresis, so check sodium every 4 to 6 hours.
- Hyperkalaemia usually corrects with fluids and hydrocortisone; treat dangerous levels as in the hyperkalaemia note.
Stepping down
- Taper over 1 to 3 days as the trigger resolves, to oral hydrocortisone at double the usual dose, then back to maintenance (typically 15 to 25 mg daily in 2 or 3 doses, the largest on waking).
- Prednisolone (3 to 5 mg daily) is an alternative for maintenance; dexamethasone is avoided for long-term replacement.
Surgery and procedures
The UK peri-operative guideline (Association of Anaesthetists, RCP and Society for Endocrinology 2020) is widely used in Australia:
- Major surgery or labour: hydrocortisone 100 mg IV at induction, then 200 mg per 24 hours until eating and drinking, then double oral dose for 48 hours or longer.
- Minor procedures: double the usual oral dose on the day, or a single IV dose at the start.
Pregnancy
- Hydrocortisone needs rise in the third trimester (increase by about 20 to 40%). Give 100 mg IV at the onset of active labour or before caesarean section, then stress dosing.
- Prednisolone is acceptable; dexamethasone crosses the placenta and is avoided.
Prevention
- Sick-day rules:
- Fever above 38°C or illness needing bed rest: double the oral dose until better
- Vomiting, diarrhoea or unable to take tablets: hydrocortisone 100 mg IM and go to hospital
- Emergency kit: hydrocortisone 100 mg vial (Solu-Cortef), needle and syringe, with the patient and family taught to inject IM. Prescribe the injection so the patient holds their own supply.
- Medical alert ID and a written emergency plan. The Endocrine Society of Australia and the Australian Pituitary Foundation publish patient emergency plans and cards.
- Glucocorticoid-induced disease: anyone stopping long-term glucocorticoids should taper, and needs stress dosing for illness or surgery until HPA axis recovery is shown (ESE/Endocrine Society 2024). Refer to an endocrinologist if the axis hasn't recovered after a year on physiological doses, or after a crisis.
- Immune checkpoint inhibitors: hypophysitis (especially ipilimumab) and primary adrenalitis can present as crisis. Check morning cortisol in anyone on these drugs who becomes fatigued or hypotensive.
Complications
- Death from refractory shock or hypoglycaemia. Annual crisis rates are around 5 to 10 per 100 patient-years in known adrenal insufficiency, with roughly 0.5 deaths per 100 patient-years.
- Osmotic demyelination from over-rapid sodium correction after hydrocortisone.
- Over-replacement long term: weight gain, osteoporosis, hyperglycaemia. Aim for the lowest maintenance dose that controls symptoms.
Pitfalls
- Waiting for a cortisol result or a synacthen test before giving hydrocortisone.
- Assuming the patient on long-term prednisolone 5 mg daily for polymyalgia is safe because the dose is near physiological. The axis can still be suppressed, and illness and vomiting precipitate crisis.
- Using dexamethasone for the acute crisis in primary adrenal insufficiency. It lacks mineralocorticoid activity (though it is reasonable as a one-off to preserve a synacthen test, followed by hydrocortisone).
- Starting thyroxine before hydrocortisone in hypopituitarism.
- Missing adrenal insufficiency as the cause of falling insulin requirements and recurrent hypos in type 1 diabetes, or of unexplained hyponatraemia.
- Forgetting that bilateral adrenal haemorrhage can follow anticoagulation, heparin-induced thrombocytopenia or antiphospholipid syndrome, presenting as abdominal pain and shock.
Finished reading?
Sources
- Adrenal insufficiency: identification and management (NG243)National Institute for Health and Care Excellence, 2024
- Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guidelineEndocrine Society (Bornstein et al., J Clin Endocrinol Metab 2016;101:364-89), 2016
- European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiencyESE and Endocrine Society (Beuschlein et al., J Clin Endocrinol Metab 2024), 2024
- Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiencyAssociation of Anaesthetists, Royal College of Physicians and Society for Endocrinology UK (Woodcock et al., Anaesthesia 2020), 2020
- ECAT adult clinical tool: adrenal insufficiencyAU/NZAgency for Clinical Innovation, NSW Health
- Endocrinology (Therapeutic Guidelines)AU/NZTherapeutic Guidelines Ltd
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback